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Abstract. Gap junctions consisting of connexin 43 subunits
provide intercellular communication between astrocytes,
contributing to their function of maintaining the central nervous
system (CNS) microenvironment. Magnetic resonance imaging
(MRI) studies demonstrate prolonged astrocyte swelling related
to seizures, while in vitro studies show the disruption of inter-
cellular coupling and the cytotoxic swelling of astrocytes in
seizure-equivalent environments. We examined the relation
between astrocyte swelling and connexin 43 regulation using
an in vivo seizure model. Generalised tonic-clonic convulsions
were induced in adult rats using intraperitoneally (i.p.)-admin-
istered 4-aminopyridine (4-AP). The expression of connexin 43
mRNA and protein at 1, 3 and 24 h after seizure induction was
measured. Astrocytic swelling was assessed at the same time
points using transmission electron microscopy. mRNA and
protein levels remained unaltered at all time periods. However,
a significant (~50%) reduction was found in the amount of
phosphorylated (P1, P2) to unphosphorylated (NP) forms of
connexin 43 at 3 h. The amount increased thereafter, but was
still significantly lower than in the controls at 24 h post-
seizure. Simultaneously, marked astrocytic swelling was
measured in the neocortex. Pre-treatment with N-methyl-D-
aspartate (NMDA) receptor antagonist dizocilpine maleate
(MK-801) resulted in the amelioration of seizure symptoms
and the prevention of connexin 43 dephosphorylation, as well
as significantly reduced astrocytic swelling. Dephosphorylation
of connexin 43 was shown to reduce astrocytic gap junction
(GJ) permeability. Our results therefore suggest that, during
acute seizures, a prolonged inhibition of intercellular coupling
develops in the astrocyte network. This accounts for the long-
lasting astrocyte swelling observed, and potentially impairs
buffering function. The results also imply that this uncoupling
is regulated through neuronal and/or glial NMDA-type
glutamate receptors.
Introduction
Central nervous system (CNS) seizures are characterised by
repeated synchronised neuronal bursts, a subsequent increase
in transmitter release, and changes in volume transmission and
in the diffusion parameters of the extracellular space (1-4).
Electric activity and intercellular flow of ions and small
molecules are regulated in part by gap junctions (GJs) (5,6).
These provide neuronal and glial coupling, and are therefore
considered candidates for the pathogenesis of epilepsy (7).
Morphological studies have long indicated the presence of
GJs between glial cells as well as between neurons (8). GJs
are composed of connexin protein subunits that form two
hexameric connexon channels on adjacent cell surfaces (9,10).
Connexins are encoded by a large multigene family which has
more than 20 members in mammals (11). Certain members
of this connexin family are cell-specific in their expression;
connexin 36 is detected in neurons (12), while connexin 43 is
present in astrocytes and in ependyma cells of the CNS (13).
The connexon is assembled in the endoplasmic reticulum and
the Golgi-apparatus and then inserted into the cell membrane
to form an ‘unapposed’ connexon hemichannel (10,14). This
subsequently forms an intercellular GJ with a hemichannel
of an adjacent cell (10). The conduction properties of the
connexin 43 hemichannels are influenced by the phosphoryla-
tion state of the connexin protein subunits; dephosphorylation
causes the opening of the hemichannel (15) and decreases the
formation of GJs (15,16), resulting in their closure. GJs allow
the passive flow of molecules below 1 kDa (17); therefore, the
regulation of connexons plays an important role in water-ion
homeostasis and volume transmission in the brain in both
physiological and pathological conditions (18). Astrocyte
cultures and brain slices exposed to seizure-equivalent envi-
ronments, such as high [K+]o and increased glutamate concen-
tration, displayed delayed dephosphorylation of connexin 43
and decreased coupling of astrocytes (19). The reduction of
intercellular coupling impairs the efficient trafficking of ions
and metabolites and, as such, is likely to have an impact on
glial cell volume in seizures. The long-lasting alteration of
extracellular volume transmission [i.e., the significant decrease
of the apparent diffusion coefficient (ADC) in several fore-
brain areas] coupled with the swelling of the astrocytes was
measured with magnetic resonance imaging (MRI) combined
with electron microscopy in rats during acute 4-aminopyridine
(4-AP) convulsions (4). In vitro studies elucidated the mech-
anisms underlying the initial glial swelling in response to high
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extracellular glutamate (20) and [K+]o (21). Elevated extra-
cellular glutamate levels in seizures are long-lasting - 150 min
or more (22) - but the decrease in ADC values lasts much
longer - for at least 24 h (4). We therefore investigated the
role of the neocortical astrocyte network and the possible role
of astrocytic GJs in pathological volume regulation in 4-AP
seizures. Our present experiments targeted the molecular
mechanisms of the regulation of connexin 43 in correlation
with the measurable swelling of astrocytes in the neocortex
of the convulsing rat. We investigated the role of N-methyl-
D-aspartate (NMDA) glutamate receptors in connexin 43
regulation and edema formation.
Materials and methods
Animals and treatments. Male Wistar rats weighing 200-250 g
were bred in the Central Animal House of the University of
Szeged under standard conditions with ad libitum access to
food and water. All experiments were conducted in accor-
dance with the European Community Council Directive of
November 24, 1986 (86/609/EEC) and the Hungarian
Animal Act (1998). Rats were injected intraperitoneally (i.p.)
with 4-AP (Sigma, 5 mg/kg 4-AP dissolved in physiological
saline, 1.0 mg/ml concentration). The control animals
received the same volume of physiological saline i.p.
Dizocilpine maleate (MK-801, Sigma) dissolved in physio-
logical saline was administered i.p. 10 min before 4-AP
administration at a dose of 1 mg/kg (23). Animal seizure
behaviour was evaluated as previously described by measuring
the latency of symptoms (24). Animals were observed at 1, 3
and 24 h from the time of 4-AP injection, with 3 repeats in
each group (Table I). The pharmacological effect of MK-801
was evaluated separately (10-10 animals in each group;
Table II).
Nucleic acid measurements. Animals were anesthetised with
diethyl-ether, decapitated, their brains removed, and the neo-
cortex of the right hemisphere frozen in liquid nitrogen. For
reverse-transcriptase polymerase chain reaction (RT-PCR),
the acid guanidinium-phenol-chloroform method (25) was
used to extract total-RNA, 2 μg of which was used for reverse
transcription (RT) (26). PCR was carried out with 1 μl of
20 μl RT cDNA product along with components, as previously
described (27). The sequence of connexin 43 and glycerine-
aldehyde phosphate dehydrogenase (GAPDH) primers has
been previously described (28,29).
After the linearity of connexin 43 and GAPDH was
carefully established, PCR was carried out at 17, 22 and 27
cycles. PCR products were separated on 6% acrylamide gel and
stained with ethidium bromide (Sigma). The gels were scanned
and the bands evaluated by densitometry using ImageQuant
(Typhoon™ 9400 Variable Mode Imager, Molecular
Dynamics). The densitometric values of connexin 43 mRNA
bands were normalised on GAPDH mRNA detected and
amplified from the same samples.
Protein measurements. Neocortex samples were obtained as
described above and frozen in liquid nitrogen. Regarding the
solubility of the different phosphorylated forms of connexin 43
(9), no detergents were used during protein purification. The
second portion of the samples was homogenised in ice cold
buffer (pH 7.2) containing 20 mM HEPES, 0.5 mM EDTA
and the following protease inhibitors: 1 mM phenylmethylsul-
fonyl fluoride (PMSF), 1 μM pepstatin A and 2 μM leupeptin
(28). To preserve the phosphorylated forms, 10 mM of the
phosphatase inhibitor Na3VO4 was added to the lysis buffer in
specified samples. Homogenates were centrifuged at 20,000 g
for 30 min at 4˚C, then the pellet was resuspended in homo-
genisation buffer. Alkaline phosphatase treatment was carried
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Table II. Behavioural analysis of the effect of NMDA antagonist on 4-AP seizures. 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Compounds GTCS latency (min) SEM % animals displaying GTCS
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
4-AP 30.3 1.4 100 
4-AP plus MK-801 34.2 4.5 27.7a
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Tests were conducted in groups of ten animals each. The antagonist was injected intraperitoneally. Ten minutes later, 4-AP was administered,
and the latencies of the onset of GTCS were measured from the time of the 4-AP injection (significance, ap<0.05; ANOVA followed by the
post hoc Bonferroni test). GTCS, generalised tonic-clonic seizures; SEM, standard error of the mean.
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 




Methods 4-AP (5mg/kg) MK-801 (1 mg/kg) Solvent (0.9% NaCl)
(at 1, 3, and 24 h) plus 4-AP (5 mg/kg) control
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
RT-PCR 9 (3/group) 9 3
Western blot 15 (5/group) 15 5
Electron microscopy 9 (3/group) 9 3
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
aThe evaluation of seizure symptoms was performed in a separate animal group (see Table II).
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
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out with some modifications (30). With Na3VO4 excluded,
70 μg of pre-cleaned lysate was equilibrated against 100 mM
Tris (pH 8.0), 100 mM NaCl, 5 mM MgCl2, 2 mM PMSF
and 0.6% SDS. Half the sample was treated with 2 U/sample
alkaline phosphatase at 37˚C for 4 h, and the other half was
incubated untreated. The reaction was terminated by the
addition of 200 mM Na3VO4. Samples were re-dissolved in
10% acrylamide gel with a prolonged run-time (~2.5 h at
200 V) to separate the different forms of connexin 43 (all
chemicals used for protein blotting were purchased from
Sigma). Protein was transferred by the semi-dry method
(Bio-Rad) onto polyvinylidene difluoride membranes
(Amersham) at 11 V for 50 min. Blots were blocked for 1 h at
room temperature with 5% skimmed dry milk and probed with
a 1:1,000 dilution of rabbit polyclonal connexin 43 antibody
raised against the 252-271 fragment of the protein distant
from the known sites of phosphorylation (31) for 1 h at room
temperature. The connexin 43 antibody was a generous gift
from Professors Bernard Himpens and Johan Vereecke,
Laboratory of Physiology, KU Leuven, Belgium. Following
extensive washes in phosphate-buffered saline PBS (pH 7.4)
containing 0.1% Tween, the blot was incubated with alkaline
phosphatase tagged anti-rabbit secondary antibody (Amersham)
at a dilution of 1:10,000 for 1 h at room temperature. ECF™
substrate (Amersham) was added and the blots were quantitated
with ImageQuant (Typhoon™ 9400 Variable Mode Imager,
Molecular Dynamics) as described above.
Electron microscopy. The animals were deeply anesthetised
with diethyl-ether and perfused transcardially with 250 ml
of 0.1 M PBS pH 7.4 followed by 300 ml of fixative (1%
paraformaldehyde and 1% glutaraldehyde in phosphate-
buffered solution, pH 7.4). Samples of the right parietal
cortex were prepared for electron microscopy. Following
thorough rinsing, the tissue blocks were incubated in an
aqueous solution of 1% OsO4 and 5% K2Cr4O7 (1:1). The
samples were dehydrated then incubated in 1% uranyl-acetate
and embedded in Durcupan epoxy resin (Fluka, Buchs,
Switzerland). Semithin sections were cut on an ultramicro-
tome (Ultracut E, Reichert-Jung, Vienna, Austria) and stained
on object glasses with a 1:1 mixture of 1% methylene blue
and 1% azure II blue. The samples were then coverslipped
with DPX mountant and analysed under a light microscope
(Nikon E600, Nikon Co., Tokyo, Japan). Ultra-thin sections
were cut of the same blocks and collected on 200-mesh
copper grids. The preparations were then contrasted with 5%
uranyl acetate and Reynolds lead citrate solution. Specimens
were viewed under a Philips TM10 transmission electron
microscope (Eindhoven, The Netherlands). Imaging was
acquired with a computer-assisted digital camera (MegaView
II, Soft Imaging Systems, Münster, Germany).
Approximately 900 μm2 of sample surface was viewed
systematically through all neocortical layers of the parietal
cortex, and 12±2 capillary cross sections were examined in
each specimen. The total area of the so-called neurovascular
unit, which consists of the capillary lumen, the surrounding
endothelium and the astrocytic end-feet covering the basal
lamina of the microvascular endothelium, was measured
(Image Pro Plus 4.5 morphometric software; Media Cyber-
netics, Silver Spring, MD, USA). 
Statistical analysis. Data are presented as the means ± STDEV.
Statistical analysis of the relative band densities and phospho-
rylation rates between the indicated groups were performed
using the Student's t-test and the Newman-Keuls test. One-way
analysis of variance (ANOVA) followed by the Bonferroni
post hoc test was used when comparing astrocyte end-feet
areas. SPSS 9.0 statistical software was used for analysis and
p<0.05 was considered statistically significant.
Results
Behavioural studies. The behavioural effects of the treatments
on separate groups of animals were observed (Table I). The
i.p. administration of 4-AP caused characteristic behavioural
symptoms within 15 min: tremor of the vibrissal and mastica-
tory muscles followed by a generalised tremor of the body
musculature (detectable as a continuous fasciculation of the
muscles), and then generalised tonic-clonic seizures (GTCS).
The main behavioural symptoms disappeared after 90-120 min
at most; the animals then displayed mild tremor or brief myo-
clonic episodes. By the end of the experiment, all the animals
had recovered completely. Pre-treatment with MK-801
prevented the development of GTCS in 72.3% of the animals
(Table II). The symptoms preceding GTCS (tremor of the
vibrissae, tremor of the masticatory muscles, and generalised
tremor) were not detected in animals pre-treated with MK-801.
In these rats, instead of tremor, the first symptoms were hypo-
tonia of the limbs and unsteady gait. Antagonist administered
on its own did not induce any obvious behavioural changes.
Connexin 43 mRNA expression. The levels of GAPDH and
connexin 43 mRNA were quantified in neocortex samples
collected at 1, 3 and 24 h following 4-AP and the control
physiological saline injections (not shown). In the controls as
well as in the 4-AP treated animals, the GAPDH messages
were not statistically different. Similarly, at no time were
density changes observed in the normalised connexin 43
mRNA levels when the 4-AP treated group and the control
group were compared (Fig. 1).
Connexin 43 protein phosphorylation. Previous studies have
shown that the phosphorylated forms of connexin 43 migrate
as separate bands on the gel during electrophoresis (9). These
two phosphorylated forms, P1 and P2, migrated at 44 kDa
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Figure 1. Expression of connexin 43  mRNA following acute 4-aminopyridine
(4-AP) seizures. (A) Representative gels exhibiting connexin 43 (Cx43) and
the internal control glycerine-aldehyde phosphate dehydrogenase (GAPDH)
at 1 and 3 h following seizure induction. The band indicates 300 bp fragment
length. (B) Summarised data. The relative density of the Cx43 bands is
expressed as arbitrary units (means ± STDEV, n=3).
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and 46 kDa, respectively (Fig. 2A). Non-phosphorylated
protein (NP) was detected at 42 kDa (Fig. 2A). To confirm the
phosphorylation status of the identified forms, parallel samples
were treated with alkaline phosphatase. This resulted in the
complete disappearance of the P1 and P2 bands, with a single
band left representing the NP form (Fig. 2A). The complete
insolubility of the P2 form and the partial insolubility of P1 in
Triton X-100 have been reported (9) and were confirmed by
our preliminary experiments (data not shown). Following
the method of Christ et al (28), we successfully extracted
both the phosphorylated and non-phosphorylated forms of
connexin 43 without the use of detergents, achieving optimal
protein yield (Fig. 2A). Some of the blots displayed P1 and
P2 as a single fused band representing the overall quantity of
phosphorylated connexin 43, while in other blots the P1 and
P2 forms were visible as separate bands. Because of this slight
discrepancy in migration properties, we were not able to
analyse the P1 and P2 forms separately. Therefore, during
densitometric analysis, P1 and P2 band densities were added
together, and their sum was normalised to the density level of
the NP band to determine the ratio of phosphorylated/non-
phosphorylated connexin 43 molecules. The overall quantity
of connexin 43 protein, expressed by the added density of all
bands (P1+P2+NP), showed no change in 4-AP treated tissue
compared to the control neocortex (data not shown). The
phosphorylation status of connexin 43 was unchanged at 1 h
(Fig. 2B), but at 3 h (Fig. 2C) following 4-AP treatment there
was an ~50% decrease (p=0.0017) in the ratio of phosphory-
lated versus non-phosphorylated connexin 43 forms in the
epileptic animals. Surprisingly, this dephosphorylated status
persisted until 24 h post seizure as a significant ~10% reduction
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Figure 3. Connexin 43 dephosphorylation (A and B) and seizure-associated
glial swelling (C and D) in the cerebral cortex can be reversed by MK-801
pre-treatment. (A) Representative blots showing the strong presence of
phosphorylated connexin 43 after MK-801 pre-treatment 3 h following
seizure induction. (B) Summarised data from panel A blots (n=5; p<0.01).
(C and D) Representative electron micrographs demonstrating perivascular
glial swelling at 3 h post seizure induction (C), and reduced by MK-801 pre-
treatment (D). A, astrocyte end-feet; L, capillary lumen; asterisk, red blood
cell. (E) Graph summarising percent changes in astrocytic end-feet area at 1, 3
and 24 h post 4-AP injection. Note the prolonged swelling, significant at 1, 3
and 24 h, and the protective effect of MK-801 (average ± STDEV, n=27-33;
p<0.001).
Figure 2. Expression of connexin 43 protein in the cerebral cortex following
brief acute seizures. (A) Representative blots demonstrating the phosphoryla-
tion-dephosphorylation of connexin 43 isoforms. The P2 (46 kDa), P1 (44 kDa)
and non-phosphorylated (NP, 42 kDa) forms were were detected in the control
lysate (left), whereas only the NP form was present (right) following alkaline
phosphatase treatment (Alk.). (B-D) Original blots demonstrating expression
of the phosphorylated and non-phosphorylated forms of connexin 43 at 1
(B), 3 (C) and 24 h (D) following seizure induction. Dephosphorylation is
visible at 3 and 24 h in convulsing animals (4-AP) compared to controls. (E)
Summarised data of the changes in the phosphorylation of connexin 43
following seizures. Note the decrease in phosphorylation rate at 3 h, which
remains significant at 24 h. 4-AP, convulsing animals; control, animals
injected with saline; means ± STDEV, n=5, p=0.0017 at 3 h; p<0.01 at 24 h.
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in phosphorylation (Fig 2D). To clarify the relation between
NMDA receptor activation in 4-AP seizures and the subse-
quent phosphorylation changes of connexin 43, the NMDA
antagonist MK-801 was applied prior to seizure induction.
This pre-treatment resulted in a decrease in connexin 43
dephosphorylation at 3 h (Fig. 3A and B), suggesting that the
long-lasting seizure effect was the result of an NMDA-
dependent mechanism.
Astrocyte end-feet area. In our next experiment, the area of
perivascular astrocyte processes following 4-AP seizures with
and without MK-801 pre-treatment was measured (Fig. 3C and
D). Baseline values of the astrocytic end-feet area in untreated
animals were considered to be 100% for the purposes of our
analysis. A 464% ± 85 increase in the size of the end-feet
compared to baseline was seen at 1 h following seizure induc-
tion, followed by a 471% ± 104 and 392% ± 71 increase in
size at 3 and 24h, respectively (n=29-34, p<0.001). Swelling
was abolished by the application of MK-801 with 310% ± 59,
292% ± 59 and 129% ± 45 end-feet areas in the 1, 3, and 24 h
groups, respectively (n=28-32, p<0.001) (Fig. 3E).
Discussion
The present study is the first to demonstrate the post-
translational changes of the GJ subunit connexin 43 in vivo
in epileptic animals. Our results strongly indicate that, in acute
GTCS, connexin 43 is not regulated at the transcriptional
level. The expression of connexin mRNA in our neocortical
samples was very stable in every animal group. On the other
hand, very important phosphorylation changes were observed
that were dependent on regulation processes mediated by
NMDA glutamate receptors. Several lines of evidence suggest
a regulatory role for connexin 43 in adjusting extracellular
space homeostasis by modulating intercellular communication
between CNS glial cells. Conditional knockout mice lacking
connexin 43 show a slowed decay of [Ko+] subsequent to
stimulus train (32), indicating that astrocytic GJ facilitate
intercellular K+ diffusion. A likely mechanism is that open
GJ contribute low-resistance intercellular coupling between
neighbouring cells (33), allowing the passive movement of
all particles under 1 kDa (17). Therefore, GJs facilitate the
redistribution and buffering of several ions and molecules
accumulated during GTCS, such as K+ (32,34) or glutamate
(35), via this cellular network. This has been referred to as
‘spatial buffering’ (18).
A decreased phosphorylation rate in the GJ subunit
connexin 43 was observed in response to seizures, which
corresponds to previous findings in astrocyte cultures. The
dephosphorylation of connexin 43 has been observed in
response to various pathological stimuli in vitro (19,36,37),
for example when reconstituting a seizure-like environment
with excess glutamate (1 mM) and high [K+]o (15 mM) in
brain slices (19). This dephosphorylation was demonstrated to
correspond with a reduction in intercellular coupling (16,38).
Similar responses were observed using in vitro models of
ischemia and metabolic inhibition (37,39).
Our experiments also indicate that MK-801 attenuates the
symptoms of seizures. Pre-treatment prevented the onset of
GTCS in more than 70% of the animals. MK-801 is a high-
affinity open-channel blocker that blocks the ion channel of
the receptor at the NMDA receptor, inhibiting or decreasing
the ion fluxes which follow glutamate binding (40). MK-801
administration i.p. and i.c.v. was found to protect against
4-AP seizures in electrophysiological experiments (41). The
present experiments provide further data on the important
role of glutamate and NMDA receptors in seizure pathology,
and prove that the blockage of NMDA receptor is beneficial
and decreases glial swelling significantly. These results also
increase the possibility of therapeutic applications of NMDA-
receptor antagonists for seizure-related brain edema.
The role of the phosphorylation status of connexin 43 in
the regulation of GJ permeability has been studied extensively.
The balance between the two states is set by the equilibrium
between the phosphatase PP-2B/calcineurin (38) and the
kinase c-Src (16). Both enzymes are regulated by intracellular
Ca2+ levels. As NMDA receptors permit the influx of Ca2+, it
is possible that the activation of this receptor is related to
connexin 43 dephosphorylation through the activation of
phosphatase PP-2B/calcineurin. Cytoplasmic Ca2+ may, in
response to mGluR stimulation of acute hippocampal slices,
be increased by other mechanisms, such as the release from
internal stores reported by Potter and McCarthy (42). It may
enter the cell via voltage-sensitive channels (43) and metabo-
tropic glutamate receptors during A-4P seizures as assessed
by in vivo two-photon microscopy (44). NMDA receptors are
known to be expressed in neurons (45), while astrocytes react
to glutamate by metabotropic receptors and express NMDA
subunits only under pathological conditions such as ischemia
or anoxia (46). In contrast, recent studies have clearly demon-
strated the presence of functional NMDA subunits in cortical
astrocytes in the normal brain (47,48).
MK-801 preserved connexin 43 phosphorylation in gluta-
mate-treated astrocyte cultures (19). Our results show a similar
effect in vivo; the blockage of NMDA glutamate receptors by
MK-801 inhibited connexin 43 dephosphorylation in astro-
cytes and, at the same time, significantly reduced cellular
swelling. We therefore believe that MK-801 acted not only
on neuronal, but also on astrocytic NMDA receptors in our
experiments. Consequently, NMDA receptor activation could
potentially regulate gap junction coupling in astrocytes by
modulating intracellular Ca2+ levels.
Our electron microscopy measurements demonstrate
prolonged perivascular astrocytic swelling, which was simul-
taneous to the impairment of GJ coupling (connexin 43
dephosphorylation). This implies that the latter contributes to
seizure-related glial edema. Astrocyte swelling appeared earlier
than connexin dephosphorylation, but after 3 h its decrease
followed the decrease of dephosphorylation. On the other hand,
MK-801 decreased swelling at every time point, implying that
it was largely caused by excessive glutamate release. This
long-lasting (150 min from the injection of 4-AP) significant
elevation of extracellular glutamate has been proven by our
previous experiments in 4-AP seizures (22). Therefore, we
believe that glial swelling in GTCS has two phases: Phase 1
depends on elevated extracellular glutamate and causes
swelling through the entry of Na+ and Ca2+ into the cell (42),
and Phase 2 (post-3 h) is mediated by the opening of the
hemichannels through the dephosphorylation process and the
uncoupling of the astrocytes (15,39). This second phase might
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be responsible for the decrease in ADC values at 24 h (4). GJ
proteins may exist as hemichannels, and have been shown to
respond to dephosphorylation with increased permeability.
As such, they provide a new route for solute trafficking
between the extra- and intracellular compartments (39). As
the density of hemichannels on the cell surface is not known,
we cannot estimate their contribution to astrocyte swelling in
seizures. Our results suggest that, in addition to other known
factors (e.g., aquaporins) (49) GJ and glutamate-dependent
mechanisms contribute significantly to the phases of seizure-
related glial cell swelling.
In the present study, we demonstrated the dephosphoryla-
tion of the GJ protein connexin 43 following seizures. Our
results indicate that the swelling of astrocytes and connexin
dephosphorylation are related phenomena. Based on previous
in vitro data, we propose that connexin 43 dephosphorylation
results in the closure of intercellular GJs, which in turn isolates
individual astrocytes. This mechanism may inhibit spatial
buffering and contributes to long-lasting astrocyte swelling in
seizure. The inhibition of astrocytic swelling and the simulta-
neous prevention of connexin dephosphorylation by MK-801
indicates an NMDA receptor-dependent regulatory mechanism
at work in the rat neocortex. These observations may open
up a new therapeutic avenue for re-establishing the spatial
buffering of the astrocyte network and for helping in the
recovery of brain tissue following epileptic events.
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